Home
Search:
1146 feeds
357 categories
5023 articles (<24 hours)
11 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

Science


Valid HTML 4.01 Transitional

RSS FeedsInovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer
(WorldNews Health)

 
 

26 june 2019 16:41:54

 
Inovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer
(WorldNews Health)
 




PLYMOUTH MEETING, Pa., June 26, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the completion of target enrollment of 198 participants for its pivotal Phase 3 registration trial (`REVEAL 1`) of VGX-3100, a novel DNA-based immunotherapy being tested to treat cervical dysplasia caused by human papillomavirus (HPV). Left untreated, cervical dysplasia can progress to cervical cancer. If approved, VGX-3100 would be the first immunotherapy and non-surgical alternative for women with late-stage cervical dysplasia. Dr. J. Joseph Kim, Inovio`s President & CEO, said, `This establishes an important milestone for the company as it brings Inovio another step closer to...
 
11 viewsCategory: Science > Medicine
 
The Red Cross Needs Your Help!
(WorldNews Health)
Robert Wood Johnson University Hospital Blood Services Awards $500 Scholarships to Area High School Students for Promoting Blood Donation
(WorldNews Health)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2019 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn